PMC6319687_01
(A, B) Show the PET/CT on September 2011 at the time of disease relapse. (A) Hypermetabolic omental metastasis and hypermetabolic left para aortic lymphadenopathy. (B) Hypermetabilic activity within the surgical bed representing tumor recurrence. (C, D) Show the PET/CT on March 2012 demonstrating interval resolution of hypermetabolic activity in the surgical bed, omental metastasis, and left para aortic lymph nodes.
fig-1.jpg
PMC6319687_01_fig-1.jpg
f1
The patient tolerated the therapy well, and at the end of eight cycles of treatment, he experienced a biochemical and radiographic complete response per Figure 1.
Showing cancer antigen (Ca)19-9 trend over the years during treatment of the disease.
fig-2.jpg
PMC6319687_01_fig-2.jpg
f2
Figure 2 shows the trend of the patient's Ca19-9 level during the course of his illness.